Diversified Healthcare Trust (DHC) Proxy filing summary
Event summary combining transcript, slides, and related documents.
Proxy filing summary
19 Mar, 2026Voting matters and shareholder proposals
Shareholders will vote on the election of five independent trustee nominees and two managing trustee nominees for the board, with the board recommending a vote for all nominees.
An advisory vote will be held to approve executive compensation.
Shareholders will vote to ratify the appointment of Deloitte & Touche LLP as independent auditors for the 2026 fiscal year.
Board of directors and corporate governance
The board consists of both independent and managing trustees, with seven nominees presented for election at the annual meeting.
Executive compensation and say-on-pay
An advisory vote on executive compensation is included in the meeting agenda, allowing shareholders to express approval or disapproval.
Partial view of Summaries dataset, powered by Quartr API
Latest events from Diversified Healthcare Trust
- Q2 2026 saw SHOP-driven NOI growth, margin gains, and reaffirmed guidance.DHC
Q2 2026 - Operational improvements and internal growth drive optimism for further upside.DHC
Nareit REITweek: 2026 Investor Conference - Raised 2026 guidance and strong SHOP growth drive sector-leading returns and balance sheet gains.DHC
Investor presentation - Record shareholder returns and robust SHOP growth driven by strategic asset management.DHC
Investor presentation - Q1 2026 net loss was $43.3M as SHOP NOI rose and 2026 guidance was reaffirmed.DHC
Q1 2026 - Updated sustainability metrics and climate risk strategies underscore ongoing ESG leadership.DHC
Proxy filing - Proxy covers trustee elections, say-on-pay, auditor ratification, and robust ESG and governance practices.DHC
Proxy filing - Record NOI growth, margin expansion, and debt reduction drive strong shareholder returns.DHC
Q4 2025 - SHOP segment NOI up 32.6% year-over-year, but net loss widens as asset sales and deleveraging continue.DHC
Q3 2024